News Releases

Rahway, NJ, January  24, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it will showcase its portfolio of innovative solutions to advance the poultry industry as well as offer future talent development opportunities at the International Production and Processing Expo (IPPE) in Atlanta, GA from […]

Read more

Winning veterinary student set to investigate canine distemper virus maternal antibody transfer in dogs Rahway, NJ, January 23, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK), today announced the 2023 recipient of the World Small Animal Veterinary Association (WSAVA) Michael J. Day Scholarship, Lotta Truyen. A veterinary […]

Read more

More veterinary professionals are provided access to and are pursuing mental health resources for their overall wellbeing with continued improvements on the horizon RAHWAY, N.J., Jan. 15, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today released findings of its comprehensive Veterinary Wellbeing Study conducted in collaboration […]

Read more

Rahway, NJ, December 11, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK), today announced that the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) issued a positive opinion for BRAVECTO® (fluralaner) 150 mg/ml powder and solvent for suspension for injection for dogs. The CVMP recommends the product […]

Read more

First EU-licensed vaccine proven to protect against Cryptosporidium parvum in calves from birth onwards Rahway, N.J., Nov. 29, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Commission has approved BOVILIS CRYPTIUM®, the first EU-licensed vaccine to protect cattle against Cryptosporidium parvum (C. parvum) […]

Read more

First cattle maternal vaccine effectively proven to protect against Cryptosporidium parvum in calves from birth onwards RAHWAY, N.J.,– Oct. 5, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) issued a positive opinion for BOVILIS CRYPTIUM®, […]

Read more

Company Reiterates a Commitment to Zero Dog-Mediated Human Rabies Deaths by 2030 RAHWAY, N.J., September 28, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it has donated more than 5 million NOBIVAC® rabies vaccines through the Company’s Afya Program, since it was founded. The goal […]

Read more

Symposium highlights data on an innovative, aqueous suspension of fluralaner for subcutaneous injection that was recently approved in Australia Scientific sessions highlight the importance of the One Health commitment to people, animals, environment Featured studies provide insights for otitis externa treatment, parasite prevention and infectious disease prevention RAHWAY, NJ — Sept. 27, 2023 – MSD […]

Read more

Study published in Infection and Immunity Currently no vaccine and few treatments available for cryptosporidiosis, a significant diarrheal disease in both people and animals worldwide RAHWAY, N.J., September 20, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the publication of a new study that demonstrates […]

Read more